Used in pharmaceutical research as a chiral intermediate for synthesizing biologically active compounds, particularly in the development of kinase inhibitors. Its oxazole and pyridine moieties contribute to binding selectivity in enzyme-targeted therapies. Commonly employed in asymmetric synthesis due to the stable chiral center, enabling high enantiomeric excess in final drug candidates. Also explored in the design of CNS-active agents owing to its ability to cross the blood-brain barrier.